New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - flucloxacillin sodium monohydrate 1.05 g equivalent to 1 g flucloxicillin.;   - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1.05 g equivalent to 1 g flucloxicillin.   - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - flucloxacillin sodium monohydrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg;   - capsule - 250 mg - active: flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg   excipient: colloidal silicon dioxide gelatin magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 545.3mg equivalent to flucloxacillin 500 mg;   - capsule - 500 mg - active: flucloxacillin sodium monohydrate 545.3mg equivalent to flucloxacillin 500 mg   excipient: colloidal silicon dioxide gelatin magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 27.2 mg/ml equivalent to flucloxacillin 25 mg/ml;  ; flucloxacillin sodium monohydrate 28.63 mg/ml equivalent to flucloxacillin 25 mg/ml - powder for syrup - 125 mg/5ml - active: flucloxacillin sodium monohydrate 27.2 mg/ml equivalent to flucloxacillin 25 mg/ml   excipient: ammonium glycyrrhizinate disodium edetate dihydrate erythrosine menthol flavour 17410157 pineapple flavour 17410011 saccharin sodium sodium benzoate sodium citrate dihydrate sucrose active: flucloxacillin sodium monohydrate 28.63 mg/ml equivalent to flucloxacillin 25 mg/ml excipient: citric acid monohydrate colloidal silicon dioxide disodium edetate dihydrate lemon flavour 17.41.0212 menthol flavour 17410157 saccharin sodium sodium benzoate sodium citrate sorbitol strawberry flavour 17.43.2172 xanthan gum - the treatment of infections due to gram-positive organisms, including infections caused by ?-lactamase producing staphylococci

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 54.4 mg/ml equivalent to flucloxacillin 50 mg/ml;  ; flucloxacillin sodium monohydrate 57.26 mg/ml equivalent to flucloxacillin 50 mg/ml - powder for syrup - 250 mg/5ml - active: flucloxacillin sodium monohydrate 54.4 mg/ml equivalent to flucloxacillin 50 mg/ml   excipient: ammonium glycyrrhizinate disodium edetate dihydrate erythrosine menthol flavour 17410157 pineapple flavour 17410011 saccharin sodium sodium benzoate sodium citrate dihydrate sucrose active: flucloxacillin sodium monohydrate 57.26 mg/ml equivalent to flucloxacillin 50 mg/ml excipient: citric acid monohydrate colloidal silicon dioxide disodium edetate dihydrate lemon flavour 17.41.0212 menthol flavour 17410157 saccharin sodium sodium benzoate sodium citrate sorbitol strawberry flavour 17.43.2172 xanthan gum - the treatment of infections due to gram-positive organisms, including infections caused by ?-lactamase producing staphylococci

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - flucloxacillin sodium - film-coated tablet - flucloxacillin

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - flucloxacillin sodium monohydrate, quantity: 27.2 mg/ml (equivalent: flucloxacillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: ammonium glycyrrhizinate; sodium benzoate; sucrose; saccharin sodium; disodium edetate; sodium citrate; erythrosine; flavour - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - flucloxacillin sodium monohydrate, quantity: 54.4 mg/ml (equivalent: flucloxacillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: erythrosine; sodium citrate; sodium benzoate; sucrose; ammonium glycyrrhizinate; disodium edetate; saccharin sodium; flavour - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Ireland - English - HPRA (Health Products Regulatory Authority)

ibigen srl - flucloxacillin sodium - powder for solution for injection/infusion - 250 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin